Dynavax Technologies Corp. (NASDAQ: DVAX) on Tuesday, plunged -0.25% from the previous trading day ,before settling in for the closing price of $12.05. Within the past 52 weeks, DVAX’s price has moved between $10.06 and $15.15.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 239.63%. The company achieved an average annual earnings per share of 615.60%. With a float of $130.22 million, this company’s outstanding shares have now reached $130.62 million.
Considering the fact that the conglomerate employs 408 people, you should pay attention to its efficiency factor.
Dynavax Technologies Corp. (DVAX) Insider Activity
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Dynavax Technologies Corp. is 0.30%, while institutional ownership is 96.96%. The most recent insider transaction that took place on Mar 01 ’24, was worth 262,322. In this transaction Chief Accounting Officer of this company sold 20,526 shares at a rate of $12.78, taking the stock ownership to the 0 shares. Before that another transaction happened on Jan 04 ’24, when Company’s SVP and CMO sold 1,500 for $15.00, making the entire transaction worth $22,500. This insider now owns 49,925 shares in total.
Dynavax Technologies Corp. (DVAX) Earnings and Forecasts
As on 12/30/2023, Multinational firm has announced its last quarter scores, in which it reported $0 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.01) by $0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.09 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 615.60% per share during the next fiscal year.
Dynavax Technologies Corp. (NASDAQ: DVAX) Trading Performance Indicators
Dynavax Technologies Corp. (DVAX) is currently performing well based on its current performance indicators. A quick ratio of 12.96 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.76. Likewise, its price to free cash flow for the trailing twelve months is 16.28.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.07, a number that is poised to hit -0.02 in the next quarter and is forecasted to reach 0.45 in one year’s time.
Technical Analysis of Dynavax Technologies Corp. (DVAX)
Compared to the last year’s volume of 1.95 million, its volume of 1.22 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 17.47%. Additionally, its Average True Range was 0.30.
During the past 100 days, Dynavax Technologies Corp.’s (DVAX) raw stochastic average was set at 11.01%, which indicates a significant decrease from 15.58% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 16.07% in the past 14 days, which was lower than the 26.29% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.55, while its 200-day Moving Average is $13.60. Nevertheless, the first resistance level for the watch stands at $12.07 in the near term. At $12.12, the stock is likely to face the second major resistance level. The third major resistance level sits at $12.18. If the price goes on to break the first support level at $11.96, it is likely to go to the next support level at $11.90. Should the price break the second support level, the third support level stands at $11.85.
Dynavax Technologies Corp. (NASDAQ: DVAX) Key Stats
Market capitalization of the company is 1.57 billion based on 129,300K outstanding shares. Right now, sales total 232,280 K and income totals -6,390 K. The company made 55,600 K in profit during its latest quarter, and 220 K in sales during its previous quarter.
